Standard of care (Control)

OTHER6 trials

Sponsors

Vital Therapies, Inc., Jerry Estep, MD, Abiomed Inc., University of Florida

Conditions

Acute Alcoholic HepatitisChronic Heart FailureFulminant Hepatic FailureParkinson DiseaseST-elevation Myocardial Infarction

Phase 2

Phase 2 Evaluation of the ELAD System in the Management of Acute Liver Failure

CompletedNCT00030225

Vital Therapies, Inc.Fulminant Hepatic Failure

Start: 2002-01-31End: 2003-02-28Updated: 2012-07-26

Phase 3

Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure

CompletedNCT01471028

Vital Therapies, Inc.Acute Alcoholic Hepatitis

Start: 2013-02-28End: 2015-08-31Updated: 2019-02-15

Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD

TerminatedNCT02612428

Vital Therapies, Inc.Acute Alcoholic Hepatitis

Start: 2016-01-31End: 2018-09-30Updated: 2019-01-25

Unknown Phase

Neurostimulation of Spinal Nerves That Affect the Heart

Jerry Estep, MDChronic Heart Failure

Start: 2010-05-31End: 2018-11-30Updated: 2018-01-12

MINI-AMI: Minimizing Infarct Size With Impella 2.5 Following PCI for Acute Myocardial Infarction

TerminatedNCT01319760

Abiomed Inc.ST-elevation Myocardial Infarction

Start: 2011-04-30End: 2013-03-31Updated: 2019-05-13

Mediterranean Diet Intervention to Improve Gastrointestinal Function in Parkinson's Disease a Randomized, Controlled, Clinical Trial

CompletedNCT04683900

University of FloridaParkinson Disease

Start: 2021-02-08End: 2022-06-07Updated: 2022-07-12

Related Papers

Effect of a Mediterranean diet intervention on gastrointestinal function in Parkinson’s disease (the MEDI-PD study): study protocol for a randomised controlled trial

BMJ Open2021-09-0116 citations